Molecular Templates, Inc. 2014 Equity Incentive Plan, as amended Option Agreement (Incentive Stock Option or Nonstatutory Stock Option)Option Agreement • March 30th, 2018 • Molecular Templates, Inc. • Pharmaceutical preparations • Texas
Pursuant to your Notice of Grant of Stock Options (“Grant Notice”) and this Option Agreement, Molecular Templates, Inc. (the “Company”) has granted you an option under its 2014 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. The option is granted to you effective as of the date of grant set forth in the Grant Notice (the “Date of Grant”). This Option Agreement shall be deemed to be agreed to by the Company and you upon the electronic signing or electronically accepting by you of the Grant Notice. If there is any conflict between the terms in this Option Agreement and the Plan, the terms of the Plan will control. Capitalized terms not explicitly defined in this Option Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan.
MOLECULAR TEMPLATES, INC.Stock Option Agreement • March 30th, 2018 • Molecular Templates, Inc. • Pharmaceutical preparations • Texas
Unless otherwise defined herein, the terms defined in the 2009 Stock Plan (the “Plan”) shall have the same defined meanings in this Stock Option Agreement (the “Option Agreement”).
THIRD AMENDMENT TO LEASELease • March 30th, 2018 • Molecular Templates, Inc. • Pharmaceutical preparations
This Third Amendment To Lease (“Amendment”) is dated as of this 23 day of June, 2017 (the “Execution Date”), by and between NW Austin Office Partners LLC, a Delaware limited liability company (“Landlord”), and Molecular Templates, Inc., a Delaware corporation (“Tenant”).
Second Amendment To LeaseLease • March 30th, 2018 • Molecular Templates, Inc. • Pharmaceutical preparations • California
This Second Amendment To Lease (“Amendment”) is dated as of this 29th day of March, 2017 (the “Execution Date”), by and between NW AUSTIN OFFICE PARTNERS LLC, a Delaware limited liability company (“Landlord”), and MOLECULAR TEMPLATES, INC., a Delaware corporation (“Tenant”).
